Oxprenolol
CARDIOVASCULAR SYSTEM
Also known as: (+/-)-Oxprenolol, dl-Oxprenolol, oxprenolol HCl, oxprenolol hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Oxprenolol is an ofm drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including ADRB1, ADRB2 and Htr1a. Recorded indications include Angina pectoris, Anxiety, Hypertensive disorder and Ventricular arrhythmia.
- Approval status: ofm.
- Molecular targets: ADRB1, ADRB2, Htr1a and SLC22A1 (4 listed in DrugCentral).
- Indications: Angina pectoris, Anxiety, Hypertensive disorder and Ventricular arrhythmia.
- ATC code: C07AA02 (Beta blocking agents, non-selective).
- Molecular formula: C15H23NO3; molecular weight 265.35 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (4)
- Angina pectoris
- Anxiety
- Hypertensive disorder
- Ventricular arrhythmia
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Beta-1 adrenergic receptor | ADRB1 | antagonist | Ki 8.11 |
| Beta-2 adrenergic receptor | ADRB2 | antagonist | Ki 8.00 |
| 5-hydroxytryptamine receptor 1A | Htr1a | unknown | Ki 7.03 |
| Solute carrier family 22 member 1 | SLC22A1 | unknown | IC50 4.54 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | NOVARTIS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C07AA02 | CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS › Beta blocking agents, non-selective |
C07BA02 | CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS AND THIAZIDES › Beta blocking agents, non-selective, and thiazides |
C07CA02 | CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS AND OTHER DIURETICS › Beta blocking agents, non-selective, and other diuretics |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Oxprenolol is on its molecule page.
| Molecular formula | C15H23NO3 |
|---|---|
| Molecular weight | 265.35 g/mol |
| CAS number | 6452-71-7 |
| InChIKey | CEMAWMOMDPGJMB-UHFFFAOYSA-N |
| PubChem CID | 4631 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Oxprenolol used for?
DrugCentral lists the following indications for Oxprenolol: Angina pectoris, Anxiety, Hypertensive disorder and Ventricular arrhythmia.
How does Oxprenolol work?
Its molecular targets in DrugCentral include ADRB1 (antagonist), ADRB2 (antagonist), Htr1a and SLC22A1.
What is the chemical formula of Oxprenolol?
Oxprenolol has the molecular formula C15H23NO3 and a molecular weight of 265.35 g/mol.
Browse: all drugs starting with O · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2027 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200745 — compound record and bioactivity
- PubChem CID 4631 — chemical identifiers
- DrugBank DB01580 — drug record
- FDA UNII 519MXN9YZR — substance identity
- DailyMed: FDA labels for Oxprenolol — current prescribing information (label search)
- UniProt P08588 (ADRB1) — target protein
- UniProt P07550 (ADRB2) — target protein
- UniProt O15245 (SLC22A1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.